| Gabapentinoid use in the United States 2002 through 2015 ME Johansen JAMA internal medicine 178 (2), 292-294, 2018 | 161 | 2018 |
| Cardiovascular risk and statin use in the United States ME Johansen, LA Green, A Sen, S Kircher, CR Richardson The Annals of Family Medicine 12 (3), 215-223, 2014 | 81 | 2014 |
| Assessment of publication trends of systematic reviews and randomized clinical trials, 1995 to 2017 JD Niforatos, M Weaver, ME Johansen JAMA Internal Medicine 179 (11), 1593-1594, 2019 | 76 | 2019 |
| Estimation of potential savings through therapeutic substitution ME Johansen, C Richardson JAMA internal medicine 176 (6), 769-775, 2016 | 66 | 2016 |
| Reexamining the ecology of medical care ME Johansen, SM Kircher, TR Huerta New England Journal of Medicine 374 (5), 495-496, 2016 | 51 | 2016 |
| Antiplatelet and statin use in US patients with coronary artery disease categorized by race/ethnicity and gender, 2003 to 2012 ME Johansen, JL Hefner, RE Foraker The American journal of cardiology 115 (11), 1507-1512, 2015 | 50 | 2015 |
| Statin use in very elderly individuals, 1999-2012 ME Johansen, LA Green JAMA Internal Medicine 175 (10), 1715-1716, 2015 | 43 | 2015 |
| Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension-con side of the argument RD Turgeon, AD Althouse, JB Cohen, B Enache, JB Hogenesch, ... Hypertension 78 (3), 871-878, 2021 | 36 | 2021 |
| Attention deficit hyperactivity disorder medication use among teens and young adults ME Johansen, K Matic, AS McAlearney Journal of Adolescent Health 57 (2), 192-197, 2015 | 32 | 2015 |
| National use of proton pump inhibitors from 2007 to 2011 ME Johansen, TR Huerta, CR Richardson JAMA internal medicine 174 (11), 1856-1858, 2014 | 30 | 2014 |
| The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use sodium glucose cotransporter 2 inhibitors is now ME Johansen, C Argyropoulos Clinical Cardiology 43 (12), 1376-1387, 2020 | 26 | 2020 |
| The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients AJ Fleming Jr, ME Johansen Current opinion in otolaryngology & head and neck surgery 16 (2), 127-134, 2008 | 21 | 2008 |
| Per visit emergency department expenditures by insurance type, 1996–2015 J Yun, K Oehlman, M Johansen Health Affairs 37 (7), 1109-1114, 2018 | 18 | 2018 |
| Thyroid hormone use in the United States, 1997–2016 ME Johansen, JP Marcinek, JDY Yun The Journal of the American Board of Family Medicine 33 (2), 284-288, 2020 | 17 | 2020 |
| Comparing medical ecology, utilization, and expenditures between 1996–1997 and 2011–2012 ME Johansen The Annals of Family Medicine 15 (4), 313-321, 2017 | 17 | 2017 |
| Impact of Medicare Part D on out‐of‐pocket drug costs and medical use for patients with cancer SM Kircher, ME Johansen, HS Nimeiri, CR Richardson, MM Davis Cancer 120 (21), 3378-3384, 2014 | 17 | 2014 |
| The ecology of medical care before and after the Affordable Care Act: trends from 2002 to 2016 ME Johansen, CR Richardson The Annals of Family Medicine 17 (6), 526-537, 2019 | 16 | 2019 |
| Anti-hypertensive medication combinations in the United States ME Johansen, J Yun, JM Griggs, EA Jackson, CR Richardson The Journal of the American Board of Family Medicine 33 (1), 143-146, 2020 | 14 | 2020 |
| A national survey of the treatment of hyperlipidemia in primary prevention ME Johansen, KJ Gold, A Sen, N Arato, LA Green JAMA internal medicine 173 (7), 586-588, 2013 | 12 | 2013 |
| Clinical prediction rules: challenges, barriers, and promise E Wallace, ME Johansen The Annals of Family Medicine 16 (5), 390-392, 2018 | 11 | 2018 |
